Follow
Corrado Blandizzi, MD
Corrado Blandizzi, MD
Professore di Farmacologia, Universitŕ di Pisa
Verified email at med.unipi.it
Title
Cited by
Cited by
Year
Immunity, inflammation and cancer: a leading role for adenosine
L Antonioli, C Blandizzi, P Pacher, G Haskó
Nature Reviews Cancer 13 (12), 842-857, 2013
7992013
Effective and safe proton pump inhibitor therapy in acid-related diseases–a position paper addressing benefits and potential harms of acid suppression
C Scarpignato, L Gatta, A Zullo, C Blandizzi, ...
BMC medicine 14, 1-35, 2016
3662016
Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis–an expert consensus addressing benefits as well as gastrointestinal and cardiovascular …
C Scarpignato, A Lanas, C Blandizzi, WF Lems, M Hermann, RH Hunt, ...
BMC medicine 13, 1-22, 2015
2952015
Anti-CD73 in cancer immunotherapy: awakening new opportunities
L Antonioli, GG Yegutkin, P Pacher, C Blandizzi, G Haskó
Trends in cancer 2 (2), 95-109, 2016
2342016
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?
C Pellegrini, L Antonioli, R Colucci, C Blandizzi, M Fornai
Acta neuropathologica 136, 345-361, 2018
2092018
Canonical and non-canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation
C Pellegrini, L Antonioli, G Lopez-Castejon, C Blandizzi, M Fornai
Frontiers in immunology 8, 237490, 2017
2022017
Adenosine and inflammation: what's new on the horizon?
L Antonioli, B Csóka, M Fornai, R Colucci, E Kokai, C Blandizzi, G Haskó
Drug Discovery Today 19 (8), 1051-1068, 2014
1872014
Hydrogen sulphide: novel opportunity for drug discovery
A Martelli, L Testai, MC Breschi, C Blandizzi, A Virdis, S Taddei, ...
Medicinal research reviews 32 (6), 1093-1130, 2012
1862012
Adenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations
L Antonioli, C Blandizzi, B Csóka, P Pacher, G Haskó
Nature reviews endocrinology 11 (4), 228-241, 2015
1812015
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders
L Antonioli, R Colucci, C La Motta, M Tuccori, O Awwad, F Da Settimo, ...
Current drug targets 13 (6), 842-862, 2012
1722012
Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome
C Stasi, M Bellini, G Bassotti, C Blandizzi, S Milani
Techniques in coloproctology 18, 613-621, 2014
1712014
Adenosine signaling and the immune system: When a lot could be too much
L Antonioli, M Fornai, C Blandizzi, P Pacher, G Haskó
Immunology letters 205, 9-15, 2019
1632019
Development of an acrylate derivative targeting the NLRP3 inflammasome for the treatment of inflammatory bowel disease
M Cocco, C Pellegrini, H Martínez-Banaclocha, M Giorgis, E Marini, ...
Journal of Medicinal Chemistry 60 (9), 3656-3671, 2017
1442017
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation
A Virdis, A Bacca, R Colucci, E Duranti, M Fornai, G Materazzi, C Ippolito, ...
Hypertension 62 (2), 337-344, 2013
1422013
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review
M Tuccori, A Testi, L Antonioli, M Fornai, S Montagnani, N Ghisu, ...
Clinical therapeutics 31, 1426-1453, 2009
1412009
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
M Tuccori, S Ferraro, I Convertino, E Cappello, G Valdiserra, C Blandizzi, ...
MAbs 12 (1), 1854149, 2020
1382020
molecular, pathological and therapeutic features of human enteric neuropathies
G DI NARDO, C Blandizzi, U Volta, R Colucci, V Stanghellini, G Barbara, ...
Alimentary pharmacology & therapeutics 28 (1), 25-42, 2008
1372008
Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients
A Virdis, F Santini, R Colucci, E Duranti, G Salvetti, I Rugani, C Segnani, ...
Journal of the American College of Cardiology 58 (3), 238-247, 2011
1362011
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis
L Antonioli, M Fornai, R Colucci, N Ghisu, F Da Settimo, G Natale, ...
Journal of Pharmacology and Experimental Therapeutics 322 (2), 435-442, 2007
1362007
The purinergic system as a pharmacological target for the treatment of immune-mediated inflammatory diseases
L Antonioli, C Blandizzi, P Pacher, G Haskó
Pharmacological reviews 71 (3), 345-382, 2019
1342019
The system can't perform the operation now. Try again later.
Articles 1–20